论文部分内容阅读
目的探讨观察胺碘酮治疗心力衰竭合并快速型心律失常患者的疗效。方法选取2013年11月~2014年11月院收治的心力衰竭合并快速型心律失常患者40例作为研究对象。将其随机分成观察组和对照组,各20例。两组患者均给予常规治疗,同时对观察组患者在常规治疗的基础上再加胺碘酮治疗,观察两组患者的疗效和不良反应情况,并进行比较。结果观察组的总治疗有效率比之对照组明显较高,差异显著有统计学意义(P<0.05);两组的不良反应发生率比较差异无统计学意义(P>0.05)。结论采用胺碘酮治疗心力衰竭合并快速型心律失常疗效显著、安全性高,适合在临床上应用,具有较大的推广价值。
Objective To investigate the efficacy of amiodarone in the treatment of patients with heart failure and tachyarrhythmia. Methods Forty patients with heart failure complicated with tachyarrhythmia admitted from November 2013 to November 2014 in our hospital were selected as the research object. They were randomly divided into observation group and control group, 20 cases each. Both groups were given routine treatment. At the same time, the patients in the observation group were treated with amiodarone on the basis of routine treatment. The curative effect and adverse reactions of the two groups were observed and compared. Results The total effective rate of observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). There was no significant difference in adverse reaction between the two groups (P> 0.05). Conclusions The use of amiodarone in the treatment of heart failure complicated with tachyarrhythmia has obvious curative effect, high safety, suitable for clinical application and has great promotion value.